Francesco Giuseppe Foschi

机构：Ospedale per gli Infermi · ORCID：0000-0002-8216-0918

发表论文 230 篇 · 总被引 6756 次 · h-index 40

代表论文

Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study (2024 · Oncology · 被引 9)
Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial (2024 · Liver International · 被引 7)
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison (2025 · JHEP Reports · 被引 6)
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab (2025 · Scientific Reports · 被引 4)
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis (2025 · Digestive Diseases and Sciences · 被引 4)
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab (2024 · Scientific Reports · 被引 4)